Medical charity, Doctors Without Borders says there is a desperate need for new stocks of Fav-Afrique, which neutralises 10 different snakebites that can occur in sub-Saharan Africa.
Without this drug thousands of people will unnecessarily die of snakebites.
The last batch of the drug will expire in June next year.
The company which produced the drug, Sanofi Pasteur, decided that it was no longer financially viable to continue producing the treatment.
Simon Allison, Africa Correspondent for the Daily Maverick says hundreds thousands of people are estimated to die from snake bites each year.
The cost of producing this drug is very high it costs between 250 – 300 US Dollars— Simon Allison, Africa Correspondent for the Daily Maverick
According to Allison, the process of producing Fav-Afrique is very complex.
Listen to Allison explaining the process of producing Fav-Afrique below: